The P/E ratio is the first valuation number most investors learn, and for a large slice of the dividend-paying universe it does exactly the job it was designed for. But P/E collapses the moment a company is deliberately reinvesting so hard that its earnings are suppressed — or reinvesting so hard that it doesn’t have earnings yet at all. That’s the world most non-dividend stocks live in: growth over payout, capacity over cash return, market share over margin.

DiviDrip by TwylightCrow surfaces four valuation numbers on the Valuation Multiples card inside every Stock Metrics tab: Trailing P/E, Forward P/E, P/S, and PEG. Each one is compared against the sector-peer median so a number never floats in isolation. This guide walks through what each multiple answers, when to trust it, and where it fails — using live readings from real tickers on the platform.

The four multiples at a glance

For deeper mechanics on each metric, use the Glossary links in the Related section — those entries carry the tier tables, formula variants, and caveats in full. This guide is the applied lens: how the four numbers behave together on real non-dividend tickers.

Price-to-Sales: the workhorse for growth stocks

P/S is the multiple you reach for first when a company has revenue but not yet meaningful earnings. It sidesteps every accounting choice around depreciation, stock-based compensation, tax rate, and capitalisation policy by anchoring on the top line — the number hardest to fake and easiest to compare across companies.

The trap is that a P/S number in isolation tells you almost nothing. A grocer with a 3% gross margin has no room in each sales dollar to reward shareholders — a software company with 80% gross margins does. That’s why P/S must always be read against the peer group. DiviDrip’s Valuation Multiples card sits right next to the sector-median tile so the comparison is one glance away.

Live readings across the growth spectrum

Values pulled live from the platform’s Massive-sourced ratio cache. Open the Stock Metrics tab on any of these tickers to see the current numbers alongside sector-median comparisons.

EV/EBITDA: the acquirer’s lens

Two companies can have identical P/E ratios and yet be very differently priced — because one is funded almost entirely with equity and the other carries meaningful debt. EV/EBITDA fixes that by adding debt back onto the numerator (and taking cash off) so you’re comparing total business value, not just the equity slice.

Where it earns its keep for non-dividend investors is in capex-heavy stories. GAAP earnings are depressed by depreciation charges on data centers, factories, streaming catalogs, or vehicle fleets — but those depreciation charges are non-cash. EBITDA adds them back to get closer to the pre-investment cash economics. When you’re trying to judge whether Netflix’s pre-2020 content-driven cash losses were rational, or whether Uber’s expansion machinery is finally scaling, EV/EBITDA is a cleaner lens than P/E.

The rough tier map inside the Glossary entry: below 8 is generally cheap for most industries, 8-15 is fair, above 18 is priced for growth or a premium franchise. But sector matters enormously — utilities structurally sit at 10-14, software can sustain 20+ during expansion phases, and cyclicals swing wildly around their trough and peak years. Never read EV/EBITDA without the peer-group context.

PEG: adjusting valuation for growth

P/E on its own doesn’t tell you whether a 30x multiple is justified. PEG (P/E divided by earnings growth rate) attempts to make P/Es comparable across companies growing at different speeds. The classic reading, from Peter Lynch’s One Up on Wall Street, is that a PEG near 1.0 is fair, under 1.0 is potentially undervalued, and over 1.0 means the market is paying up for growth.

PEG’s biggest weakness is the growth estimate that goes into it. Broker forward-growth forecasts have a bias toward optimism and can be revised sharply after a single guide-down. A useful discipline: any time PEG looks “too good to be true,” cross-reference against the company’s 3-year and 5-year trailing revenue and EPS CAGRs before trusting it.

Live PEG readings

Reading the multiples together

No single multiple wins on its own. The value of the Valuation Multiples card is the composite picture. A few common patterns worth naming:

• P/E and P/S both above sector median, PEG below 1: Priced for growth, but priced fairly if the growth actually shows up. Example fingerprint: current NVDA, META. Track quarterly guidance discipline.
• P/S in line with sector, PEG well above 1: The market is paying a growth premium the top line doesn’t yet reflect. Usually a re-rating waiting to happen — either the growth accelerates or the multiple compresses. Cross-reference with Operating Momentum before deciding which.
• P/E extreme, P/S moderate: Reinvestment suppressing near-term earnings. This is Amazon 2010-2020 or Netflix 2015-2019. If Free Cash Flow is genuinely improving, the P/E is misleading. Read the Free Cash Flow Growth guide before writing off a stock on P/E alone.
• P/S extreme, no earnings: Pure narrative premium. History says this is the fastest tier to compress when growth decelerates. Palantir at 58x sales and Tesla at 15x sales both sit in this bucket right now. Position size accordingly.

Historical inflections worth remembering

Amazon (AMZN) — a 20-year lesson in why P/E was the wrong lens

For most of the 2004-2015 window Amazon carried trailing P/Es above 100 — sometimes above 500. Traditional value investors screening on P/E kept rejecting the stock. But Bezos was intentionally suppressing GAAP earnings to reinvest into AWS, logistics, and Prime. Revenue was compounding at 25-35% annually, and P/S never went above 3 for long. Investors who anchored on the P/S read got the signal that GAAP earnings failed to give. Amazon returned roughly 1,900% over the decade from 2010 to 2020, and the best single-metric explanation is that P/S never priced in the level of platform dominance the business was building.

Netflix (NFLX) — the great multiple-compression of 2022

In early 2021 Netflix traded near a P/S of 10 with revenue growth still comfortably above 20%. When the Q1 2022 earnings release showed the first quarterly subscriber loss in more than a decade, the market re-rated the growth story almost overnight. The P/S compressed from 10 to below 3 inside twelve months even though revenue growth stayed positive. The lesson: at a P/S of 10, the price was already assuming continued acceleration — and any deceleration, even mild, breaks the thesis. Today NFLX has settled around a P/S of 6.5 as an ad-supported mature-growth story.

Salesforce (CRM) — the multiple that rewarded discipline

Salesforce spent most of 2015-2021 at a P/S above 8, funded by aggressive M&A (MuleSoft, Tableau, Slack). When the 2022 macro turn forced a company-wide focus on operating leverage, revenue growth moderated but margins improved. Today CRM sits near a P/S of 2.9 — the lowest reading in a decade — alongside a Rule of 40 score that has stayed cleanly in Healthy tier. The setup is unusual: a multiple that’s compressed toward mature-industrials levels while the efficiency picture stayed intact. Whether that’s a value setup or a value trap turns entirely on whether AI-agent revenue actually re-accelerates the top line in the next four quarters.

The 60-second valuation check

1. Open the stock modal and select the Stock Metrics tab. The Valuation Multiples card is the second tile from the top.
2. Read all four tiles at once — Trailing P/E, Forward P/E, P/S, PEG — against the sector-median comparison.
3. Ask three questions in order: (1) Is the company profitable today? If no, skip P/E and PEG and lean on P/S plus forensic safety. (2) Is P/S materially above the sector median? If yes, the story better include real growth acceleration. (3) Does PEG line up with the trailing 3-year growth, not just the broker forward estimate?
4. Cross-reference with the Rule of 40 and the FCF Growth check. The multiples answer “how much are you paying?” Those two answer “what are you paying for?” You need both to size a position with conviction.

Where these multiples sit in the bigger picture

The Valuation Multiples card is meant to be the fastest possible sanity check — four numbers that anchor whatever fuller analysis you do next. None of them feed the Capital Reinvestment Score directly, because valuation is deliberately kept out of the composite: a great business at a bad price is a different problem than a bad business at any price, and the Capital Reinvestment Score answers the second question, not the first. Use the multiples to judge whether the entry price is defensible, then use the Capital Analytics tab to judge whether the business is worth owning at any price.

FAQ

Why can’t I just use P/E for non-dividend stocks?

You often can, but the P/E ratio breaks in two common non-dividend situations. First: pre-profit companies. If EPS is negative or zero, P/E is either negative (mathematically valid, financially meaningless) or undefined. That covers most early-stage biotech, a lot of clinical-stage medtech, and any high-growth software still investing ahead of profitability. Second: extreme-growth companies where trailing earnings badly understate the future. Tesla trades near a trailing P/E of 413 right now — that number alone tells you almost nothing about whether the stock is expensive relative to what the business will earn two years from now. That’s where P/S, EV/EBITDA, and PEG step in.

Is a low P/S always cheap and a high P/S always expensive?

No — P/S has to be read against the business’s gross margin and growth rate. A grocer with 3% gross margins can’t sustain a P/S above 1 for long, because there’s no profit trapped inside each dollar of sales to reward investors. A software company with 80% gross margins can rationally trade at a P/S of 15 or higher, because most of every incremental dollar of revenue will drop to the bottom line at scale. So a P/S of 2 is expensive for a supermarket but cheap for enterprise software. Always compare a stock’s P/S to its own industry median before drawing conclusions — the “vs sector” comparison on DiviDrip’s Valuation Multiples card does this for you.

Why does DiviDrip show P/E even for non-dividend stocks that also use P/S and PEG?

Because for every non-dividend stock that IS already profitable, P/E is still the most widely-cited number on Wall Street — and having it visible lets you sanity-check the P/S read. Amazon, Netflix, Meta, Alphabet, and Nvidia all have real, positive earnings today, and their P/E ratios (around 29, 23, 21, 27, and 30 respectively as of this writing) tell you the market is pricing them like premium compounders rather than moonshots. The Valuation Multiples card intentionally shows all four (Trailing P/E, Forward P/E, P/S, PEG) so you can triangulate. If P/E and P/S agree that a stock looks stretched, that’s a stronger signal than either metric alone.

What is EV/EBITDA and when should I care about it?

EV/EBITDA divides Enterprise Value (market cap plus debt minus cash) by EBITDA (earnings before interest, taxes, depreciation, and amortization). The point is to strip out capital-structure and tax-regime noise so you can compare companies apples-to-apples across countries, sectors, and levels of leverage. Investment bankers use it more than P/E because it’s the multiple actual acquirers pay when they buy a business outright. It’s especially useful for capital-intensive non-dividend stocks — think Uber, Netflix pre-2020, cable and telecom rollups, or capex-heavy industrials — where large depreciation charges distort GAAP earnings. Rough guideposts: below 8 is generally cheap, 8-15 is fair, above 18 is priced for growth. It’s directional, not deterministic — always cross-reference the peer group.

How do I read PEG in practice?

PEG = P/E divided by the expected earnings growth rate expressed as a whole-number percent. Classic interpretation is that PEG near 1.0 means the price is roughly fair for the growth on offer, PEG below 1.0 is potentially undervalued, and PEG above 1.0 means investors are paying up for the growth. But PEG is only as good as the growth estimate feeding it. Salesforce’s current PEG of 0.30 looks like a screaming bargain until you remember that PEG uses forward growth estimates that have been repeatedly cut over the last two years for enterprise software. Meta’s PEG near 0.52 and Nvidia’s near 0.33 look elite, but they’re predicated on the market believing the AI-capex cycle keeps translating into earnings. Trust PEG most when the growth rate is trailing and verified — not when it’s a broker projection.

What multiple do I use for a company with no revenue yet?

None of these work for a truly pre-revenue company (early-stage biotech, some clinical medtech, some pre-launch tech). You fall back to non-price-based frameworks: cash runway (how many quarters of operating expenses does the balance-sheet cash cover?), pipeline value (probability-weighted net present value of each drug candidate or product line), and the founder / operator record. This is the terrain where Forensic Safety (Altman Z-score, Beneish M) matters more than valuation multiples — if the business runs out of cash before it produces revenue, no multiple would have saved you. See our guide on Beneish + Altman for the safety gate.

Try it

Pull up a non-dividend name you’re curious about on the Dashboard and open the Stock Metrics tab. Read the four multiples top-to-bottom, then flip to Capital Analytics for the efficiency and quality picture. Compare a mature compounder (ADBE or AAPL if you allow the dividend-payer exception), a heavy reinvestor (AMZN), an elite-growth story (NVDA or PLTR), and a compression casualty (CRM). The shape of the four numbers together will tell you more about market sentiment than any single one on its own.

For the full definitions, tier tables, and formula caveats, see the P/S, EV/EBITDA, and PEG glossary entries.

This guide is educational. Multiples are directional signals, not price targets — pair them with forensic safety checks and a read of the latest 10-Q before committing capital. Historical performance is not a forecast.